Delivery Order SPE2DB25D3201-SPE2DB26FNNVW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,650.56 to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL intravenous solution in 150 mL bottles. This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, reflects a firm fixed-price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,454.80 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL in 100 mL bottles. This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a non-competitive award under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,475.92 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,847.40 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This is a firm fixed-price delivery order with an ultimate completion date of November 28, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,597.96 to supply Visipaque 320 mg/mL infusion bottles (150 mL) with an ultimate completion date of December 9, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and...
- The Defense Logistics Agency awarded a $4,847.40 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles. This is a firm fixed price contract with a completion deadline of December 9, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,063.20 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml) on August 28, 2025, with completion targeted for August 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,301.12 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units). This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract falls under...
- The Defense Logistics Agency awarded a delivery order valued at $11,396.08 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL in 100 mL bottles. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. Visipaque is a contrast medium used in medical imaging procedures, reflecting the critical role of...
- The Defense Logistics Agency awarded a $5,006.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This contract, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award for pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNVWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,837.07 to AmerisourceBergen Drug Corp for the supply of Visipaque 270 mg/ml in 150 ml bottles. This order, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract exemplifies the routine pharmaceutical procurement conducted through DLA's established medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves critical federal medical procurement needs for military and veteran healthcare systems, supplying an extensive portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's firm fixed-price contracting approach and demonstrated capability to compete for federal medical supplies underscore its role as a key vendor supporting DLA's mission to provision defense and military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/4/25 |